Defining and Validating Comorbidities and Procedures in ICD-10 Health Data in ST-elevation Myocardial Infarction Patients
Overview
Affiliations
Administrative health databases are used in research to define comorbid conditions, diagnosis, and procedures. Our objectives were to validate a diagnosis of ST-elevation myocardial infarction (STEMI) and invasive cardiac procedure coding against a comprehensive registry of STEMI patients and determine an optimal algorithm for defining comorbidities using administrative hospitalization and ambulatory databases, but without using a physician claims database, which is unavailable for use in many jurisdictions.A registry of consecutive STEMI patients was used to define a reference cohort and linked to the hospitalization and ambulatory databases. Four administrative case definitions for defining comorbidities, as well as STEMI diagnosis and in-hospital procedures using the International Classification of Diseases, 10th Revision (ICD-10) and the Canadian Classification of Health Interventions (CCI) were evaluated. Metrics were used to evaluate algorithm performance and compare discriminative ability using the C statistic.The 3236 patients had median age of 60 years (interquartile range 52-71) and 75.7% were male. A diagnosis of STEMI was correctly identified in the administrative records for 3043 (94.0%) patients. In-hospital procedures (coronary artery bypass grafting, percutaneous coronary intervention, and angiogram) were well identified using administrative definitions (Kappa statistic 0.83-1.00). Validation of comorbidities varied by condition but an algorithm using 2 inpatient/ambulatory visits in the previous 2 years maximized PPV, ranging from 28.6% for previous heart failure to 95.7% for previous MI. The c statistic was similar for each of the methods, ranging from 0.76 to 0.80.ICD-10 and CCI codes can identify hospitalized STEMI patients with high sensitivity and accurately define in-hospital cardiac procedures. Comorbidities can be defined with high PPV using a definition of 2 inpatient/ambulatory visits in the previous 2 years.
Gatuz M, Abu-Fanne R, Abramov D, Barel M, Mamas M, Roguin A Am Heart J Plus. 2024; 46:100452.
PMID: 39319104 PMC: 11419879. DOI: 10.1016/j.ahjo.2024.100452.
Andresen K, Hinojosa-Campos M, Podmore B, Drysdale M, Qizilbash N, Cunnington M Drug Healthc Patient Saf. 2024; 16:1-17.
PMID: 38192299 PMC: 10771726. DOI: 10.2147/DHPS.S415292.
Lin S, Shermeyer A, Nikpay S, Hsia R, Ward M Acad Emerg Med. 2023; 31(2):119-128.
PMID: 37921055 PMC: 11025473. DOI: 10.1111/acem.14831.
Ward M, Nikpay S, Shermeyer A, Nallamothu B, Rokos I, Self W JAMA Netw Open. 2023; 6(6):e2317831.
PMID: 37294567 PMC: 10257096. DOI: 10.1001/jamanetworkopen.2023.17831.
Patel K, Majmundar M, Vasudeva R, Doshi R, Kaur A, Mehta H Am J Cardiol. 2023; 198:14-25.
PMID: 37196529 PMC: 10184571. DOI: 10.1016/j.amjcard.2023.04.030.